ResMed Inc (0KW4.L)

Name: ResMed Inc Financial Statements
Creator: Quarter Results

Healthcare | Medical Devices

Latest reporting period: 2026-03-31

Latest Quarter

2026-03-31

Revenue

$1.4B

Net Income

$399M

Operating Margin

34.9%

Free Cash Flow

$1.7B

Debt / Assets

27.0%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for ResMed Inc (0KW4.L).
Income Statement (Quarterly)	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Revenue	1,431,406,000	1,422,808,000	1,335,582,000	1,347,993,000
Cost of Revenue	540,427,000	538,148,000	514,762,000	527,923,000
Gross Profit	890,979,000	884,660,000	820,820,000	820,070,000
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	279,797,000	278,396,000	259,194,000	265,125,000
Operating Expenses	391,169,000	387,065,000	374,283,000	365,527,000
Operating Income	499,810,000	497,595,000	446,537,000	454,540,000
Interest Expense	12,287,000	7,949,000	8,793,000	0
Income Before Tax	502,312,000	496,147,000	446,793,000	458,053,000
Income Tax Expense	103,580,000	103,554,000	98,257,000	78,348,000
Net Income	398,732,000	392,593,000	348,536,000	379,705,000
Per Share
EPS	2.72	2.69	2.38	2.59
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for ResMed Inc (0KW4.L).
Income Statement (Annual)	2025-06-30	2024-06-30	2023-06-30
Revenue	5,146,327,000	4,685,297,000	4,222,993,000
Cost of Revenue	2,091,357,000	2,029,994,000	1,867,331,000
Gross Profit	3,054,970,000	2,655,303,000	2,355,662,000
Operating Expenses
R&D Expenses	0	0	0
SG&A Expenses	991,019,000	917,136,000	874,003,000
Operating Expenses	1,369,607,000	1,335,410,000	1,203,665,000
Operating Income	1,685,363,000	1,319,893,000	1,131,871,000
Interest Expense	12,609,000	45,708,000	47,379,000
Income Before Tax	1,677,566,000	1,264,798,000	1,101,664,000
Income Tax Expense	276,843,000	243,847,000	204,108,000
Net Income	1,400,723,000	1,020,951,000	897,556,000
Per Share
EPS	9.55	6.94	6.12
EPS Diluted	0.00	0.00	0.00

Balance sheet quarterly history for ResMed Inc (0KW4.L).
Balance Sheet (Quarterly)	2025-06-30	2024-06-30	2023-06-30
Assets
Cash and Cash Equivalents	1,209,450,000	238,361,000	227,891,000
Short Term Investments	0	0	12,423,000
Net Receivables	990,667,000	837,275,000	704,909,000
Inventory	927,711,000	822,250,000	998,012,000
Total Current Assets	3,505,605,000	2,357,719,000	2,367,830,000
Property Plant Equipment	718,287,000	699,146,000	665,811,000
Goodwill and Intangibles	3,511,541,000	3,327,959,000	3,322,640,000
Total Assets	8,174,391,000	6,872,394,000	6,751,708,000
Liabilities
Account Payables	278,157,000	237,728,000	150,756,000
Short Term Debt	40,406,000	35,178,000	53,740,000
Total Current Liabilities	1,019,120,000	910,655,000	758,533,000
Long Term Debt	811,407,000	838,757,000	1,548,087,000
Total Liabilities	2,206,532,000	2,008,351,000	2,621,805,000
Shareholders Equity
Retained Earnings	6,081,490,000	4,991,647,000	4,253,016,000
Total Shareholders Equity	5,967,859,000	4,864,043,000	4,129,903,000

Balance sheet annual history for ResMed Inc (0KW4.L).
Balance Sheet (Annual)	2025-06-30	2024-06-30	2023-06-30
Assets
Cash and Cash Equivalents	1,209,450,000	238,361,000	227,891,000
Short Term Investments	0	0	12,423,000
Net Receivables	990,667,000	837,275,000	704,909,000
Inventory	927,711,000	822,250,000	998,012,000
Total Current Assets	3,505,605,000	2,357,719,000	2,367,830,000
Property Plant Equipment	718,287,000	699,146,000	665,811,000
Goodwill and Intangibles	3,511,541,000	3,327,959,000	3,322,640,000
Total Assets	8,174,391,000	6,872,394,000	6,751,708,000
Liabilities
Account Payables	278,157,000	237,728,000	150,756,000
Short Term Debt	40,406,000	35,178,000	53,740,000
Total Current Liabilities	1,019,120,000	910,655,000	758,533,000
Long Term Debt	811,407,000	838,757,000	1,548,087,000
Total Liabilities	2,206,532,000	2,008,351,000	2,621,805,000
Shareholders Equity
Retained Earnings	6,081,490,000	4,991,647,000	4,253,016,000
Total Shareholders Equity	5,967,859,000	4,864,043,000	4,129,903,000

Cash flow quarterly history for ResMed Inc (0KW4.L).
Cash Flow Statement (Quarterly)	2025-06-30	2024-06-30	2023-06-30
Operating Activities
Net Income	1,400,723,000	1,020,951,000	897,556,000
Depreciation & Amortization	235,811,000	216,209,000	197,562,000
Stock Based Compensation	91,661,000	80,184,000	71,142,000
Change in Working Capital	16,738,000	44,784,000	-462,127,000
Operating Cash Flow	1,751,588,000	1,401,260,000	693,299,000
Investing Activities
Capital Expenditure	-89,865,000	-114,856,000	-134,000,000
Investments	-89,865,000	-99,460,000	-134,000,000
Investing Cash Flow	-200,045,000	-269,784,000	-1,159,845,000
Financing Activities
Debt Repayment	-40,000,000	-730,000,000	665,000,000
Common Stock Issued/Repurchased	-225,586,000	-96,917,000	49,142,000
Dividends Paid	-310,880,000	-282,320,000	-258,276,000
Financing Cash Flow	-606,253,000	-1,119,287,000	422,874,000
Summary
Free Cash Flow	1,661,723,000	1,286,404,000	559,299,000
Net Change in Cash	971,089,000	10,470,000	-45,819,000

Cash flow annual history for ResMed Inc (0KW4.L).
Cash Flow Statement (Annual)	2025-06-30	2024-06-30	2023-06-30
Operating Activities
Net Income	1,400,723,000	1,020,951,000	897,556,000
Depreciation & Amortization	235,811,000	216,209,000	197,562,000
Stock Based Compensation	91,661,000	80,184,000	71,142,000
Change in Working Capital	16,738,000	44,784,000	-462,127,000
Operating Cash Flow	1,751,588,000	1,401,260,000	693,299,000
Investing Activities
Capital Expenditure	-89,865,000	-114,856,000	-134,000,000
Investments	-89,865,000	-99,460,000	-134,000,000
Investing Cash Flow	-200,045,000	-269,784,000	-1,159,845,000
Financing Activities
Debt Repayment	-40,000,000	-730,000,000	665,000,000
Common Stock Issued/Repurchased	-225,586,000	-96,917,000	49,142,000
Dividends Paid	-310,880,000	-282,320,000	-258,276,000
Financing Cash Flow	-606,253,000	-1,119,287,000	422,874,000
Summary
Free Cash Flow	1,661,723,000	1,286,404,000	559,299,000
Net Change in Cash	971,089,000	10,470,000	-45,819,000